Knockdown of MCM3 resulted in significant enhancement of tamoxifen-induced apoptotic cell death in tamoxifen-resistant breast cancer cell lines (Fig. 5a, b), while no significant difference was observed in the absence of tamoxifen, with the exception of TamR-7. This evidence concerns the gene MCM3 and breast carcinoma.